Influence of the configurational pattern of sp(2)-iminosugar pseudo N-, S-, O- and C-glycosides on their glycoside inhibitory and antitumor properties

Carbohydr Res. 2016 Jun 24:429:113-22. doi: 10.1016/j.carres.2016.01.006. Epub 2016 Jan 21.

Abstract

The synthesis of a complete series of cyclic carbamate-type sp(2)-iminosugar N-, S-, O- and C-octyl pseudoglycosides related to nojirimycin, mannojirimycin and galactonojirimycin, all having the α-pseudoanomeric configuration, is reported. The gem-diamine-type N-pseudoglycosides can be accessed directly from the corresponding reducing sp(2)-imisosugar precursors by reaction with octylamine in methanol, whereas per-O-acetyl or 1-fluoro derivatives were used as pseudoglycosyl donors for the preparation of S-pseudoglycosides or O- and C-pseudoglycosides, respectively. Evaluation of their inhibitory properties against a panel of glycosidases evidenced selectivity profiles that strongly depend on the configurational pattern and the nature of the glycosidic linkage. On the contrary, the antiproliferative activity determined against a panel of tumor cell lines was largely independent of the relative orientation of the hydroxyl groups in the sp(2)-iminosugar moiety. Indeed, sp(2)-iminosugar representatives exhibiting significant growth inhibition potencies were identified in all three configurationally different types of compounds studied, namely α-d-gluco, α-d-manno and α-d-galacto glycoside analogs. Interestingly, none of the compounds affected viability and mortality of normal cells at the used concentrations. Altogether, the results strongly suggest that the anticancer activity of amphiphilic sp(2)-iminosugar glycosides might be unrelated, or not solely related, to their glycosidase inhibitory activity.

Keywords: Antitumor activity; Glycosidase inhibitor; Glycosides; Nojirimycin; sp(2)-Iminosugar.

MeSH terms

  • Amines / chemistry
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology
  • Galactose / analogs & derivatives
  • Glucose / analogs & derivatives
  • Glycoside Hydrolases / antagonists & inhibitors*
  • Glycoside Hydrolases / chemistry
  • Glycosides / chemical synthesis*
  • Glycosides / pharmacology
  • Humans
  • Imino Sugars / chemical synthesis*
  • Imino Sugars / pharmacology
  • Inhibitory Concentration 50
  • Mannose / analogs & derivatives
  • Methanol / chemistry
  • Organ Specificity
  • Structure-Activity Relationship

Substances

  • Amines
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Glycosides
  • Imino Sugars
  • Glycoside Hydrolases
  • Glucose
  • Mannose
  • octylamine
  • Galactose
  • Methanol